The global molecular diagnostics market was valued at USD 4.3 billion in 2012 and is expected to grow at a CAGR of 11.1 % from 2013 to 2019, to reach an estimated value of USD 8.7 billion in 2019.Molecular diagnostics primarily refers to a class of diagnostic test that analyzes nucleic acids or proteins at a molecular level. This class of diagnostics is identified as rapidly evolving and fastest growing segment of in-vitro diagnostics industry. Moreover, it is also considered as the most attractive and well established market for clinical applications. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. But reduction in cost per sample analysis and labor cost, improvements in automation and introduction of advanced technologies has expanded the usage of molecular diagnostics in wide range of applications. The market for molecular diagnostics has expanded since 1990’s with the introduction of PCR test for HIV and Chlamydia Trachomatis / Neisseria Gonorrhoeae(CT/NG). It is estimated that in the U.S. over 600 laboratories and 200 independent laboratories perform molecular diagnostics test to simplify and accelerate the testing proces.

1. Transparency Market Research (TMR) provides a range of marketing
and business research solutions designed for your specific needs. From
off-the-shelf syndicated business & market research to made-to-order
custom research, we serve our clients to fulfill their immediate as well
as ongoing research requirements.
Contact Us : State Tower,90 State Street,Suite 700,Albany NY – 12207,United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

2. Molecular Diagnostics Market - Global
Industry Analysis, Size, Share,
Growth, Trends and Forecast, 2013 2019
Single User
License: US $
4795
Buy Now
Request Sample
Multi User
License: US $
7795
122
Pages
Report
Corporate
User License:
US $ 10795
Published Date : Feb
2014

3. PR : Molecular Diagnostics Market (PCR, Next Generation
Sequencing, Microarray, Infectious diseases, Genetic disease,
Oncology testing, Blood donor screening) Expected to Reach USD
8.7 Billion Globally in 2019: Transparency Market Research
Transparency Market Research is Published new Market Report “Molecular Diagnostics
Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic
disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast, 2013 - 2019," the global molecular diagnostics market was
valued at USD 4.3 billion in 2012 and is expected to grow at a CAGR of 11.1 % from 2013
to 2019, to reach an estimated value of USD 8.7 billion in 2019.
Molecular diagnostics is defined as a class of diagnostic tests that identifies proteins or
nucleic acid at a molecular level. This class of test assists in identification of genetic markers
of patient or nucleic acids in foreign organism. Currently, molecular diagnostics forms
relatively a small portion of the overall diagnostics market but is identified as the fastest
growing sector. The growth of this segment is being supported by rapid turnaround time,
low cost, convenient workflow and high sensitivity. Moreover, growth of this segment is
fuelled by rising incidence of chronic disorders, increasing geriatric population and adoption
of personalized medicines. Molecular diagnostics test is rapidly being developed for genetic
testing, infectious diseases testing, blood screening, oncology testing, cardiovascular testing
and others.
Molecular diagnostics is rapidly an evolving market supported by increasing R&D activities
for biomarker identification coupled with emergence of new applications of these tests.
Infectious disease alone captures 60% share of the total molecular diagnostics applications
market and remaining one third is attributed to genetic testing and blood donor screening.
The growth of this segment is driven by rising incidence of cervical cancer caused due to
Human Papilloma Virus (HPV). HPV is known to be a causative agent for cervical cancers
hence HPV testing is projected to have a CAGR of 14.8% during the forecast period of 20132019. Hospital acquired infections (HAI)is anticipated as the fastest growing segment within
infectious diseases and is expected to show CAGR of 15.1% from 2013-2019. Oncology
testing and HLA typing testing are also projected to grow at a rapid rate during the same
forecast period.
Technology wise, PCR accounts for the largest share followed by Transcription Mediated
Amplification (TMA), with these two technologies accounting for nearly 50% of the share of
molecular diagnostics market. Next generation sequencing is expected to witness the
highest growth rate in the near future. High sensitivity, reliability and rapid turnaround time

4. are some of the factors that are expected to trigger market growth. Microarray and
hybridization techniques are also expected to show moderate growth. However, issues with
reimbursement policies and strict regulatory requirements are some factors, expected to
hinder the growth of molecular diagnostics market.
Browse Molecular Diagnostics Market Report with Full TOC at
http://www.transparencymarketresearch.com/molecular-diagnosticsindustry.html
Geographically, North America and Europe comprises majority of the molecular diagnostics
market share. Increasing investments in genomics and proteomics, rising awareness and
acceptance of personalized medicines along with increasing incidence of chronic diseases
are some of the factors that have driven the molecular diagnostics industry in these regions.
However, Asia-Pacific is projected to witness fastest growth rate during the forecast period,
reporting a CAGR of more than 14%. Economic developments and rising patient awareness
towards wellness, preventive medicine and access to technologically advanced products are
some of the key growth factors in this region. Additionally, growth in this market is fuelled
by spread of infectious diseases such as H1N1, HIV, rise in aging population, and robust
government support.
Molecular diagnostics market is highly fragmented comprising small and large vendors.
Roche Diagnostics is expected to lead the market owing to its extensive product portfolio in
the molecular diagnostics segment. Other players of this market include Novartis
Diagnostics, Abbott Laboratories, Qiagen, Hologic Gen-Probe, among others.
The Molecular Diagnosticsmarket is segmented as follows:
Molecular DiagnosticsMarket, by Technology

PCR

Transcription mediated amplification (TMA)

Next generation sequencing

Microarray

Hybridization techniques

Others
Molecular DiagnosticsMarket, by Application
Infectious diseases

5. Virology

HIV testing

HPV testing

HCV testing

Others
Bacteriology

HAI testing

CT/NG testing

Others
Genomics

Genetic Testing for Inherited Disorders

Human Leukocyte Antigen (HLA) Testing

Pharmacogenetics Testing

Oncology Testing

Blood Donor Screening

Others
Molecular DiagnosticsMarket, by Geography

North America

Europe

Asia-Pacific

RoW
Related & Recently Published Reports by Transparency Market Research

Browse Report With TOC : Contact Lens Market

6. 
Biopreservation Market:
http://www.transparencymarketresearch.com/biopreservationmarket.html

Organ Preservation Solutions Market:
http://www.transparencymarketresearch.com/organ-preservationsolutions.html

3D Printing Market : http://www.transparencymarketresearch.com/3dprinting-industry.html

Breakfast Cereals Market:
http://www.transparencymarketresearch.com/breakfast-cerealsindustry.html
Table of
Content
Chapter 1 Preface
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019)
2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers

7. 3.2.1 Rising incidence of cancer cases
3.2.2 Aging population
3.2.3 Increase in incidence of chronic diseases
3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized
medicines
3.3 Market Restraints
3.3.1 Issues with reimbursement policies
3.4 Market Opportunities
3.4.1 Technological advancements
3.4.2 Tapping the emerging economies
3.5 Porter’s Five Force Analysis: Global Molecular Diagnostics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by
Geography
Chapter 4 Molecular Diagnostics Market, by Technology
4.1 Overview
4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
4.2 Polymerase Chain Reaction (PCR)
4.2.1 Global PCR Market, 2011 – 2019 (USD Million)
4.3 Transcription Mediated Amplification (TMA)
4.3.1 Global TMA Market, 2011 – 2019 (USD Million)
4.4 Microarray

8. 4.4.1 Global Microarray Market, 2011 – 2019 (USD Million)
4.5 Hybridization (ISH and FISH)
4.5.1 Global Hybridization Market, 2011 – 2019 (USD Million)
4.6 Next-generation sequencing
4.6.1 Global Next generation sequencing Market, 2011 – 2019 (USD Million)
4.7 Others
4.7.1 Global Others Market, 2011 – 2019 (USD Million)
Chapter 5 Global Molecular Diagnostics Market, by Applications
5.1 Overview
5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Infectious Diseases
5.2.1 Global Infectious Diseases Market, by Segments, 2011 – 2019 (USD Million)
5.2.2 Virology
5.2.2.1 Global Virology Market, by Segments, 2011 – 2019 (USD Million)
5.2.2.2 Human immunodeficiency virus (HIV) testing
5.2.2.2.1 Global HIV testing Market, 2011 – 2019 (USD Million)
5.2.2.3 Human papillomavirus (HPV) testing
5.2.2.3.1 Global HPV testing Market, 2011 – 2019 (USD Million)
5.2.2.4 Hepatitis C virus (HCV) testing
5.2.2.4.1 Global HCV testing Market, 2011 – 2019 (USD Million)
5.2.2.5 Others
5.2.2.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
5.2.3 Bacteriology
5.2.3.1 Global Bacteriology Market, by Segments, 2011 – 2019 (USD Million)
5.2.3.2 Hospital Acquired Infection (HAI) testing

9. 5.2.3.2.1 Global HAI testing Market, 2011 – 2019 (USD Million)
5.2.3.3 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing
5.2.3.3.1 Global CT/NG testing Market, 2011 – 2019 (USD Million)
5.2.3.4 Others
5.2.3.4.1 Global Others testing Market, 2011 – 2019 (USD Million)
5.3 Genomics
5.3.1 Global Genomics Market, by Segments, 2011 – 2019 (USD Million)
5.3.2 Genetic testing for inherited disorders
5.3.2.1 Global Genetic testing for inherited disorders Market, 2011 – 2019 (USD
Million)
5.3.3 Human Leukocyte Antigen (HLA)testing
5.3.3.1 Global HLA testing Market, 2011 – 2019 (USD Million)
5.3.4 Pharmacogenetics testing
5.3.4.1 Global Pharmacogenetics testing Market, 2011 – 2019 (USD Million)
5.3.5 Oncology testing
5.3.5.1 Global Oncology testing Market, 2011 – 2019 (USD Million)
5.4 Blood Donor Screening
5.4.1 Global Blood donor screening testing Market, 2011 – 2019 (USD Million)
5.5 Others
5.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
Chapter 6 Global Molecular Diagnostics Market, by Geography
6.1 Overview
6.1.1 Global Molecular Diagnostics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019
(Value %)
6.3 North America

10. 6.3.1 North America Molecular Diagnostics Market, by Application, 2011 – 2019 (USD
Million)
6.3.2 North America Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD
Million)
6.4 Europe
6.4.1 Europe Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.4.2 Europe Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia Pacific Molecular Diagnostics Market, by Application, 2011 – 2019 (USD
Million)
6.5.2 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD
Million)
6.6 RoW
6.6.1 RoW Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.6.2 RoW Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
Chapter 7 Global Molecular Diagnostics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Molecular Diagnostics Market
7.1.1 Global Molecular Diagnostics Market Share Analysis, by Key Players, 2012 (%)
7.1.2 Competitive Position of Key Players by Segment : Global Molecular Diagnostics
Market
Chapter 8 Recommendations
8.1 Market Strategies for Success
8.1.1 Long term contracts with healthcare service providers
8.1.2 Investing in emerging economies such as China, India and Russia
8.1.3 Broadening of distribution network

11. Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Becton Dickinson & Company
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 bioMerieux
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 Bio-Rad
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Cepheid

12. 9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Danaher Corporation (Beckman Coulter)
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Hologic, Inc. (Gen-Probe)
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Myriad Genetics, Inc.
9.9.1 Company Overview
9.9.2 Financial Performance

13. 9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Novartis International AG
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.11 Qiagen
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Quest Diagnostics, Inc.
9.12.1 Company Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Siemens AG
9.13.1 Company Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies

14. 9.13.5 Recent Developments
9.14 Thermo Fisher Scientific
9.14.1 Company Overview
9.14.2 Financial Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.14.5 Recent Developments
About Us
Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze
information.
Our data repository is continuously updated and revised by a team of research experts, so
that it always reflects the latest trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary and secondary research
techniques in developing distinctive data sets and research material for business reports.
Browse all Medical Devices Market Research Reports @
http://www.transparencymarketresearch.com/medical-devices-market-reports6.html

15. Contact us :
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog : www.medicaldevicesnews.wordpress.com